Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
J Cardiovasc Electrophysiol ; 34(12): 2573-2580, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-37890039

RESUMO

INTRODUCTION: Accessory pathway (AP) ablation is a straightforward approach with high success rates, but the fluoroscopy time (FT) is significantly longer in conventional technique. Electroanatomical mapping systems (EMS), reduce the FT, but anatomical and activation mapping may prolong the procedure time (PT). The fluoroscopy integration module (FIM) uses prerecorded fluoroscopy images and allows ablation similar to conventional technique without creating an anatomical map. In this study, we investigated the effects of combining the FIM with traditional technique on PT, success, and radiation exposure. METHODS: A total of 131 patients who had undergone AP ablation were included in our study. In 37 patients, right and left anterior oblique (RAO-LAO) images were acquired after catheter placement and integrated with the FIM. The ablation procedure was then similar to the conventional technique, but without the use of fluoroscopy. For the purpose of acceleration, anatomical and activation maps have not been created. Contact-force catheters were not used. 94 patients underwent conventional ablation using fluoroscopy only. RESULTS: FIM into AP ablation procedures led to a significant reduction in radiation exposure, lowering FT from 7.4 to 2.8 min (p < .001) and dose-area product from 12.47 to 5.8 µGym² (p < .001). While the FIM group experienced a reasonable longer PT (69 vs. 50 min p < .001). FIM reduces FT regardless of operator experience and location of APs CONCLUSION: Combining FIM integration with conventional AP ablation offers reduced radiation exposure without compromising success rates and complication.


Assuntos
Feixe Acessório Atrioventricular , Ablação por Cateter , Humanos , Ablação por Cateter/efeitos adversos , Ablação por Cateter/métodos , Doses de Radiação , Feixe Acessório Atrioventricular/diagnóstico por imagem , Feixe Acessório Atrioventricular/cirurgia , Fatores de Tempo , Fluoroscopia/métodos , Resultado do Tratamento
2.
Am J Cardiol ; 166: 53-57, 2022 03 01.
Artigo em Inglês | MEDLINE | ID: mdl-34973688

RESUMO

Pulmonary vein (PV) automaticity is an established trigger for paroxysmal atrial fibrillation (PAF), making PV isolation (PVI) the cornerstone of catheter ablation. However, data on triggers for atrial fibrillation (AF) and catheter ablation strategy in very young patients aged <30 years are sparse. A total of 51 young patients (mean age 24.0 ± 4.2 years, 78.4% men) with drug-refractory PAF underwent electrophysiology (EP) study and ablation at 5 EP centers. None of the patients had structural heart disease or family history of AF. EP study induced supraventricular tachycardia (SVT) in 12 patients (n = 12, 23.5%): concealed accessory pathway mediated orthodromic atrioventricular reentrant tachycardia in 3 patients, typical atrioventricular nodal reentrant tachycardia in 6 patients, left superior PV tachycardia in 1 patient, left atrial appendage tachycardia in 1 patient, and typical atrial flutter in 1 patient. In patients with induced SVTs, SVT ablation without PVI was performed as an index procedure, except for the patient with atrial flutter who received cavotricuspid isthmus ablation in addition to PVI. Remaining patients underwent radiofrequency (n = 15, 29.4%) or second-generation cryoballoon-based PVI (n = 24, 47%). There were no major complications related to ablation procedures. Follow-up was based on outpatient visits including 24-hour Holter-electrocardiogram at 3, 6, and 12 months after ablation, or additional Holter-electrocardiogram was ordered in case of symptoms suggesting recurrence. Recurrence was defined as any atrial tachyarrhythmia (ATA) episode >30 seconds after a 3-month blanking period. A total of 2 patients with atrioventricular nodal reentrant tachycardia, 1 with left atrial appendage tachycardia, experienced AF recurrence within the first 3 months and received PVI. After the 3-month blanking period, during a median follow-up of 17.0 ± 10.1 months, 44 of 51 patients (86.2%) were free of ATA recurrence. In the PVI group, 33 of 39 patients (84.6%) experienced no ATA recurrence. In conclusion, SVT substrate is identified in around a quarter of young adult patients with history of AF, and targeted ablation without PVI may be sufficient in the majority of these patients. PVI is needed in the majority and is safe and effective in this population.


Assuntos
Fibrilação Atrial , Flutter Atrial , Ablação por Cateter , Criocirurgia , Veias Pulmonares , Taquicardia por Reentrada no Nó Atrioventricular , Taquicardia Paroxística , Taquicardia Supraventricular , Adulto , Fibrilação Atrial/diagnóstico , Criocirurgia/métodos , Feminino , Humanos , Masculino , Veias Pulmonares/cirurgia , Recidiva , Taquicardia , Taquicardia por Reentrada no Nó Atrioventricular/diagnóstico , Taquicardia por Reentrada no Nó Atrioventricular/cirurgia , Taquicardia Paroxística/cirurgia , Resultado do Tratamento , Adulto Jovem
4.
J Cardiovasc Electrophysiol ; 32(2): 360-369, 2021 02.
Artigo em Inglês | MEDLINE | ID: mdl-33355963

RESUMO

AIMS: Mahaim-type accessory pathways (MAPs) are generally right-sided due to the embryological differentiation, but left-sided localization is also possible. This study aims to compare the clinical and electrophysiological characteristics of right- and left-sided MAPs. METHODS: Of 251 patients diagnosed with AP by electrophysiological study between November 2015 and February 2020, 12 patients with MAP were included (right sided n = 8, left sided n = 4). MAP was diagnosed if; (1) no retrograde conduction; (2) anterograde decremental conduction; (3) adenosine sensitivity; and (4) Mahaim potential at successful ablation site were present. RESULTS: Ten of twelve MAPs were clustered on the lateral walls of the mitral (n = 3, 75%) and tricuspid annuli (n = 7, 87.5%). Right-sided MAPs were mostly long pathways extending toward the conduction system whereas left-sided MAPs were short extending toward the neighboring myocardium. For right- and left-sided APs, the median QRS times were 129 and 156 ms (p = .042), the median VAbl -RVApex intervals were -12 and 64 ms (p = .007), the median QRS-V(His) intervals were 16 and 86 ms (p = .120), and the median VAbl -QRS interval was -8 and 12 ms (p = .017), respectively. Coexistence of dual atrioventricular node physiology was observed only in right-sided APs (n = 3, 37.5%). CONCLUSION: MAPs are more typically located on the right but may rarely be seen on the left. Catheter ablation was associated with high success without complications.


Assuntos
Feixe Acessório Atrioventricular , Ablação por Cateter , Pré-Excitação Tipo Mahaim , Taquicardia por Reentrada no Nó Atrioventricular , Feixe Acessório Atrioventricular/cirurgia , Eletrocardiografia , Sistema de Condução Cardíaco/cirurgia , Humanos , Pré-Excitação Tipo Mahaim/cirurgia , Taquicardia por Reentrada no Nó Atrioventricular/cirurgia
5.
J Interv Card Electrophysiol ; 57(1): 5-26, 2020 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-31828560

RESUMO

Premature ventricular complexes (PVCs) are common arrhythmias in the clinical setting. PVCs in the structurally normal heart are usually benign, but in the presence of structural heart disease (SHD), they may indicate increased risk of sudden death. High PVC burden may induce cardiomyopathy and left ventricular (LV) dysfunction or worsen underlying cardiomyopathy. Sometimes PVCs may be a marker of underlying pathophysiologic process such as myocarditis. Identification of PVC burden is important, since cardiomyopathy and LV dysfunction can reverse after catheter ablation or pharmacological suppression. This state-of-the-art review discusses pathophysiology, clinical manifestations, how to differentiate benign and malignant PVCs, PVCs in the structurally normal heart, underlying SHD, diagnostic procedures (physical examination, electrocardiogram, ambulatory monitoring, exercise testing, echocardiography, cardiac magnetic resonance imaging, coronary angiography, electrophysiology study), and treatment (lifestyle modification, electrolyte imbalance, medical, and catheter ablation).


Assuntos
Complexos Ventriculares Prematuros/diagnóstico , Complexos Ventriculares Prematuros/terapia , Diagnóstico Diferencial , Humanos , Complexos Ventriculares Prematuros/fisiopatologia
6.
Anatol J Cardiol ; 20(4): 241-245, 2018 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-30297583

RESUMO

In endocrine diseases, hormonal changes, electrolyte abnormalities, and the deterioration of heart structure can lead to various arrhythmias. In diabetic patients, hypoglycemia, hyperglycemia, and hypokalemia can trigger arrhythmias, and diabetic cardiomyopathy can also cause electrical and structural remodeling to form substrates for arrhythmias. The risk of atrial fibrillation (AF) increases in hyperthyroidism; however, the prevalence of ventricular arrhythmias in hypothyroidism is higher. Besides AF and ventricular tachycardias, bradycardias and atrioventricular blocks can also be seen in pheochromocytoma due to the desensitization of adrenergic cardiovascular receptors. The correction of metabolic and electrolyte disturbances in patients with adrenal cortex disease should be the main approach in the prevention and treatment of arrhythmias. Early initiation of treatment in patients with acromegaly seems to decrease the development of cardiac remodeling and ventricular arrhythmia. Early and late after depolarizations due to hypercalcemia in hyperparathyroidism can lead to life-threatening ventricular arrhythmias. This elegant position paper provides important recommendations regarding prevention and treatment of arrhythmias for specific endocrine disorders.


Assuntos
Antiarrítmicos/uso terapêutico , Arritmias Cardíacas/tratamento farmacológico , Doenças do Sistema Endócrino , Guias de Prática Clínica como Assunto , Antiarrítmicos/administração & dosagem , Europa (Continente) , Humanos , Sociedades Médicas
7.
J Interv Card Electrophysiol ; 49(1): 33-38, 2017 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-28299537

RESUMO

PURPOSE: Lead dislocations of pacemaker systems are reported in all and even in high-volume centers. Repeated procedures necessitated by lead dislocations are associated with an increased risk of complications. We investigated a minimal invasive method for right atrial and ventricular lead repositioning. METHODS: The minimal invasive method was applied only when passive fixation leads were implanted. During the minimal invasive procedure, a steerable catheter was advanced through the femoral vein to move the distal end of the lead to the appropriate position. Retrospective data collection was conducted in all patients with minimal invasive and with conventional method, at a single center between September 2006 and December 2012. RESULTS: Forty-five minimal invasive lead repositionings were performed, of which eight were acutely unsuccessful and nine electrodes re-dislocated after the procedure. One hundred two leads were repositioned with opening of the pocket during the same time, including the ones with unsuccessful minimal invasive repositionings. One procedure was acutely unsuccessful in this group and four re-dislocations happened. A significant difference of success rates was noted (66.6% vs. 95.1%, p = 0.001). One complication was observed during the minimal invasive lead repositionings (left ventricular lead microdislodgement). Open-pocket procedures showed different types of complications (pneumothorax, subclavian artery puncture, pericardial effusion, hematoma, fever, device-associated infection which necessitated explantation, atrial lead dislodgement while repositioning the ventricular one, deterioration of renal function). CONCLUSIONS: The minimal invasive method as a first alternative is safe and feasible. In those cases when it cannot be carried out successfully, the conventional method is applicable.


Assuntos
Átrios do Coração/cirurgia , Ventrículos do Coração/cirurgia , Procedimentos Cirúrgicos Minimamente Invasivos/efeitos adversos , Procedimentos Cirúrgicos Minimamente Invasivos/métodos , Marca-Passo Artificial/efeitos adversos , Complicações Pós-Operatórias/etiologia , Implantação de Prótese/métodos , Idoso , Eletrodos Implantados/efeitos adversos , Feminino , Humanos , Masculino , Complicações Pós-Operatórias/diagnóstico , Complicações Pós-Operatórias/prevenção & controle , Implantação de Prótese/efeitos adversos , Reoperação/efeitos adversos , Reoperação/métodos , Estudos Retrospectivos , Resultado do Tratamento
8.
Eur J Med Genet ; 59(6-7): 320-4, 2016 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-27167729

RESUMO

Congenital generalized lipodystrophy type 4 is an extremely rare autosomal recessive disorder. We report our clinical experience on two unrelated Turkish patients with congenital generalized lipodystrophy type 4. A 13-year-old girl (patient-1) presented with generalized lipodystrophy and myopathy. Further tests revealed ventricular and supraventricular arrhythmias, gastrointestinal dysmotility, atlantoaxial instability, lumbosacral scoliosis, and metabolic abnormalities associated with insulin resistance. A 16-year-old girl (patient-2) with congenital generalized lipodystrophy type 4 was previously reported. Here, we report on her long term clinical follow-up. She received several course of anti-arrhythmic treatments for catecholaminergic polymorphic ventricular tachycardia and rapid atrial fibrillation. An implantable cardioverter defibrillator was also placed. A homozygous PTRF mutation, c.259C > T (p.Gln87*), was identified in patient-1. Congenital generalized lipodystrophy type 4 was caused by homozygous PTRF c.481-482insGTGA (p.Lys161Serfs*41) mutation in patient-2. Our data indicate that patients with congenital generalized lipodystrophy type 4 should be meticulously evaluated for cardiac, neuromuscular, gastrointestinal and skeletal diseases, as well as metabolic abnormalities associated with insulin resistance.


Assuntos
Arritmias Cardíacas/genética , Resistência à Insulina/genética , Lipodistrofia Generalizada Congênita/genética , Proteínas de Ligação a RNA/genética , Adolescente , Arritmias Cardíacas/fisiopatologia , Arritmias Cardíacas/terapia , Feminino , Homozigoto , Humanos , Lipodistrofia Generalizada Congênita/fisiopatologia , Lipodistrofia Generalizada Congênita/terapia , Mutação , Linhagem , Taquicardia Ventricular/genética , Taquicardia Ventricular/fisiopatologia , Taquicardia Ventricular/terapia , Turquia
9.
J Interv Card Electrophysiol ; 46(2): 153-9, 2016 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26814840

RESUMO

PURPOSE: Electroanatomical mapping is a useful tool during the ablation of atrial fibrillation. Respiratory movement might influence the mapping accuracy and merging. This study aims to investigate the effect of respiratory gating on the accuracy of magnetic-field-based electroanatomical mapping under spontaneous respiration. METHODS: Fifty-one consecutive patients (35 male, aged 30-78 years) who underwent left atrial radiofrequency catheter ablation due to atrial fibrillation were included. Electroanatomical mapping was performed with CARTO 3 System under conscious sedation. Respiratory gating was achieved with the AccuResp algorithm (Biosense Webster). Average surface match and maximum distance of the pre-acquired and electroanatomical maps, as well as left atrial volume, were recorded with and without respiratory gating after merging. RESULTS: The average surface match of the electroanatomical map with the left atrial reconstruction was significantly better with respiratory gating than without using the algorithm (3.81 ± 1.09 vs 4.11 ± 1.61 mm, p = 0.0119). It was not dependent of the rhythm during mapping or the image modality used for left atrial reconstruction. The maximal distance between the two maps did not depend on the use of the algorithm (19.81 ± 6.24 mm for gated and 20.87 ± 7.99 mm for non-gated, p = 0.3161). Left atrial volume of the map was significantly lower when using the respiratory compensation module (106.3 ± 31.6 vs 127.0 ± 36.4 ml, p < 0.0001) and showed a significant correlation with the pre-recorded 3D reconstruction volumes (r = 0.66, p < 0.0001). CONCLUSIONS: The use of the novel respiratory gating algorithm might improve the accuracy of electroanatomical mapping during left atrial ablation under conscious sedation. The possible impact on the effectiveness of the ablation needs to be further evaluated.


Assuntos
Fibrilação Atrial/diagnóstico , Fibrilação Atrial/cirurgia , Mapeamento Potencial de Superfície Corporal/métodos , Ablação por Cateter/métodos , Técnicas de Imagem de Sincronização Respiratória , Cirurgia Assistida por Computador/métodos , Adulto , Algoritmos , Sedação Consciente , Feminino , Humanos , Aumento da Imagem/métodos , Imageamento Tridimensional , Masculino , Movimento (Física) , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Resultado do Tratamento
10.
Am J Case Rep ; 15: 330-2, 2014 Aug 04.
Artigo em Inglês | MEDLINE | ID: mdl-25087767

RESUMO

PATIENT: Female, 56. FINAL DIAGNOSIS: Isolated adult interrupted aortic arch. SYMPTOMS: Headache • hypertension • left ventricular hypertrophy. MEDICATION: -. CLINICAL PROCEDURE: -. SPECIALTY: Surgery. OBJECTIVE: Congenital defects/diseases. BACKGROUND: Interrupted aorta is a rare congenital malformation defined as the lack of continuity between the ascending and descending parts of the aorta. CASE REPORT: This malformation was first described by Steidele in 1778. To date a few isolated adult interrupted aortic arch patients have been reported and most of them were treated surgically. However, there is not data about outcome of patients who decline surgery or who are not good candidates for surgery because of excessive risks, and there is not a data about how to follow these patients. CONCLUSIONS: Herein we present a case of adult type A isolated interrupted aorta followed-up for 4 years by medical therapy without complications.


Assuntos
Aorta Torácica/anormalidades , Compostos de Bifenilo/uso terapêutico , Di-Hidropiridinas/uso terapêutico , Hidroclorotiazida/uso terapêutico , Tetrazóis/uso terapêutico , Malformações Vasculares/tratamento farmacológico , Angiografia , Angiotensina II , Bloqueadores do Receptor Tipo 1 de Angiotensina II/uso terapêutico , Aorta Torácica/diagnóstico por imagem , Velocidade do Fluxo Sanguíneo , Pressão Sanguínea/efeitos dos fármacos , Bloqueadores dos Canais de Cálcio/uso terapêutico , Diuréticos/uso terapêutico , Quimioterapia Combinada , Feminino , Seguimentos , Humanos , Irbesartana , Pessoa de Meia-Idade , Tomografia Computadorizada Multidetectores , Fatores de Tempo , Malformações Vasculares/diagnóstico por imagem , Malformações Vasculares/fisiopatologia
11.
Turk Kardiyol Dern Ars ; 40(3): 229-34, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22864318

RESUMO

OBJECTIVES: This study examines university graduation rates among individuals with congenital heart disease (CHD) in comparison to their healthy peers. The effect of disease severity, type of surgery, and timing of surgery on graduation rate was also evaluated. STUDY DESIGN: One hundred forty-five male patients with CHD at military age were enrolled in the study between the dates of January 2005 and May 2007. Severity of disease was operationalised in term of initial diagnosis (According to classification of 32th ACC Bethesta Conference Task Force 1). University graduation rates of among two groups of CHD patients (mild disease (group 1) or moderate to severe disease (group 2)) are compared to each other and to healthy peers. RESULTS: Patients with CHD have reduced rates of participation in higher education compared with healthy individuals (13.1% vs 20.7%, p=0.01). Furthermore, this negative effect on education participation rate is independent of the severity of disease (group 1, 16.4%, p=0.01; group 2, 9.7%, p<0.001). Although the university graduation rate was relatively higher in patients with mild disease severity, no significant difference was found between the two patient groups (p=0.23). Having an operation does not effect graduation rate (p=0.58), however greater age at the time of operation increases the likelihood of graduation (p=0.02). CONCLUSION: Being born with CHD significantly reduces the chance of completing higher education. This negative impact on university graduation rate is independent of the severity of the disease. No negative effects of disease related surgery or subsequent corrective surgery on education were observed. Patients who were operated on later in life were more likely to complete university education. Mean operation age of this group corresponds to the typical age during the last year of elementary school in Turkey.


Assuntos
Escolaridade , Cardiopatias Congênitas/epidemiologia , Adulto , Cardiopatias Congênitas/psicologia , Cardiopatias Congênitas/cirurgia , Humanos , Masculino , Índice de Gravidade de Doença , Turquia/epidemiologia , Universidades , Adulto Jovem
12.
Turk Kardiyol Dern Ars ; 39(8): 635-45, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22257801

RESUMO

OBJECTIVES: A growing body of data illustrates the importance of microalbuminuria (MAU) as a strong predictor of cardiovascular risk in the hypertensive population. The present study was designed to define the prevalence of MAU and associated cardiovascular risk factors among Turkish hypertensive outpatients. STUDY DESIGN: Representing the Turkish arm of the multinational i-SEARCH study involving 1,750 sites in 26 countries around the world, a total of 1,926 hypertensive patients from different centers were included in this observational and cross-sectional survey study. Patients with reasons for a false-positive MAU test were excluded. The prevalence of MAU was assessed using a dipstick test, and patients were inquired about comorbidities, comedication, and known cardiovascular risk factors. RESULTS: The overall prevalence of MAU was 64.7% and there was no difference between genders. Most of the patients (82.5%) had uncontrolled hypertension, 35.6% had dyslipidemia, and 35.5% had diabetes, predominantly type 2. Almost one-third of the patients (26.4%) had at least one cardiovascular-related comorbidity, with 20.3% having documented coronary artery disease (CAD). Almost all patients (96.8%) had one or more risk factors for cardiovascular disease in addition to hypertension, including family history of myocardial infarction or CAD, diabetes, dyslipidemia, lack of physical exercise, and smoking. A trend towards higher MAU values in the presence of CAD was determined. CONCLUSION: Microalbuminuria tests should be routinely used as a screening and monitoring tool for the assessment of subsequent cardiovascular morbidity and mortality among hypertensive patients.


Assuntos
Albuminúria/epidemiologia , Doenças Cardiovasculares/epidemiologia , Hipertensão/epidemiologia , Adulto , Albuminúria/complicações , Albuminúria/urina , Doenças Cardiovasculares/complicações , Doenças Cardiovasculares/urina , HDL-Colesterol/sangue , LDL-Colesterol/sangue , Estudos Transversais , Feminino , Humanos , Hipertensão/complicações , Hipertensão/urina , Masculino , Pessoa de Meia-Idade , Prevalência , Fatores de Risco , Triglicerídeos/sangue , Turquia/epidemiologia , Urinálise , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA